Cargando…
Drug Resistance in Visceral Leishmaniasis
Visceral leishmaniasis remains a public health problem worldwide. This illness was included by the World Health Organization in the list of neglected tropical diseases targeted for elimination by 2015. The widespread emergence of resistance to pentavalent antimonials in India where half cases occur...
Autor principal: | Maltezou, Helena C. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2771279/ https://www.ncbi.nlm.nih.gov/pubmed/19888437 http://dx.doi.org/10.1155/2010/617521 |
Ejemplares similares
-
Evaluating drug resistance in visceral leishmaniasis: the challenges
por: HENDRICKX, S, et al.
Publicado: (2018) -
Visceral leishmaniasis: Experimental models for drug discovery
por: Gupta, Suman, et al.
Publicado: (2011) -
Epidemiology of visceral leishmaniasis
por: Ready, Paul D
Publicado: (2014) -
Elevated TGF-beta levels in drug-resistant visceral leishmaniasis
por: Elmekki, Miskelyemen A., et al.
Publicado: (2016) -
Therapeutic Options for Visceral Leishmaniasis
por: Monge-Maillo, Begoña, et al.
Publicado: (2013)